Diferencia entre revisiones de «Template:Phototherapy guidelines»

Sin resumen de edición
 
Línea 44: Línea 44:
*Medium Risk: (≥38 weeks + risk factors) or (35-37 weeks and no risk factors)
*Medium Risk: (≥38 weeks + risk factors) or (35-37 weeks and no risk factors)
*High Risk: 35-37 weeks + risk factors
*High Risk: 35-37 weeks + risk factors
;Note: Phototherapy is only used for an indirect hyperbilirubinemia
;Phototherapy is only used for an indirect hyperbilirubinemia

Revisión actual - 21:17 1 jul 2021

Phototherapy guidelines for neonatal jaundice

Total Bilirubin Cutoff by Risk Group
Age Low Risk Medium Risk High Risk
Birth 7.0 5.0 4.0
24h 11.5 9.0 8.0
48h 15 14 10
72h 17.5 15 14
96h 20 17.5

14.5

5+days 21 17.5 15
  • Low Risk: ≥38 weeks + no risk factors
  • Medium Risk: (≥38 weeks + risk factors) or (35-37 weeks and no risk factors)
  • High Risk: 35-37 weeks + risk factors
Phototherapy is only used for an indirect hyperbilirubinemia